methamphetamine has been researched along with dihydrotetrabenazine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frey, K; Kilbourn, M; Robinson, T | 1 |
| Hogan, KA; Sonsalla, PK; Staal, RG | 1 |
| Brown, JM; Fleckenstein, AE; Hanson, GR | 1 |
| Brown, JM; Fleckenstein, AE; Gibb, JW; Hansen, JP; Hanson, GR; Riddle, EL; Sandoval, V | 1 |
| Cho, AK; Kuczenski, R; Melega, WP; O'Neil, ML; Segal, DS | 1 |
| Fantegrossi, WE; Hatzidimitriou, G; Kilbourn, M; Ricaurte, GA; Sherman, P; Winger, G; Woods, JH; Woolverton, WL; Yuan, J | 1 |
| Boileau, I; Guttman, M; Houle, S; Kish, SJ; Rusjan, P; Saint-Cyr, JA; Selby, P; Tong, J; Wilkins, D; Wilson, AA | 1 |
| Crooks, PA; Ding, D; Dwoskin, LP; Nickell, JR | 1 |
| Boileau, I; Furukawa, Y; Houle, S; Kish, SJ; McCluskey, T; Tong, J | 1 |
9 other study(ies) available for methamphetamine and dihydrotetrabenazine
| Article | Year |
|---|---|
Reduced striatal vesicular monoamine transporters after neurotoxic but not after behaviorally-sensitizing doses of methamphetamine.
Topics: Animals; Autoradiography; Carrier Proteins; Central Nervous System Stimulants; Corpus Striatum; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Nerve Tissue Proteins; Neuropeptides; Protein Binding; Rats; Rats, Sprague-Dawley; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 1997 |
Analysis of VMAT2 binding after methamphetamine or MPTP treatment: disparity between homogenates and vesicle preparations.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Dopamine Agents; Histological Techniques; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Mice; Neuropeptides; Synaptic Vesicles; Synaptosomes; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2000 |
Methamphetamine rapidly decreases vesicular dopamine uptake.
Topics: Animals; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; Neurons; Neuropeptides; p-Chloroamphetamine; Rats; Rats, Sprague-Dawley; Serotonin Antagonists; Synaptic Vesicles; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2000 |
Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.
Topics: Animals; Biological Transport; Body Temperature; Cell Membrane; Cocaine; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; Hallucinogens; Kinetics; Male; Membrane Glycoproteins; Membrane Transport Proteins; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Nerve Tissue Proteins; Neuropeptides; Neurotoxins; Rats; Rats, Sprague-Dawley; Synaptic Vesicles; Tetrabenazine; Vesicular Biogenic Amine Transport Proteins; Vesicular Monoamine Transport Proteins | 2002 |
Escalating dose methamphetamine pretreatment alters the behavioral and neurochemical profiles associated with exposure to a high-dose methamphetamine binge.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Behavior, Animal; Binding Sites; Body Temperature; Brain Chemistry; Central Nervous System Stimulants; Cocaine; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Administration Schedule; Homovanillic Acid; Male; Methamphetamine; Motor Activity; Neostriatum; Rats; Rats, Sprague-Dawley; Stereotyped Behavior; Tetrabenazine; Time Factors; Tritium | 2003 |
Behavioral and neurochemical consequences of long-term intravenous self-administration of MDMA and its enantiomers by rhesus monkeys.
Topics: Animals; Behavior, Animal; Biogenic Monoamines; Brain; Brain Chemistry; Brain Mapping; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Cocaine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electrochemistry; Infusions, Intravenous; Macaca mulatta; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Radioligand Assay; ROC Curve; Self Administration; Serotonin Agents; Stereoisomerism; Tetrabenazine; Tissue Distribution; Tomography, Emission-Computed; Tritium | 2004 |
Increased vesicular monoamine transporter binding during early abstinence in human methamphetamine users: Is VMAT2 a stable dopamine neuron biomarker?
Topics: Adult; Analysis of Variance; Brain Mapping; Central Nervous System Stimulants; Corpus Striatum; Female; Humans; Magnetic Resonance Imaging; Male; Methamphetamine; Middle Aged; Neurologic Examination; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Substance Withdrawal Syndrome; Tetrabenazine; Time Factors; Vesicular Monoamine Transport Proteins | 2008 |
Quinolyl analogues of norlobelane: novel potent inhibitors of [(3)H]dihydrotetrabenazine binding and [(3)H]dopamine uptake at the vesicular monoamine transporter-2.
Topics: Amphetamine-Related Disorders; Animals; Binding Sites; Dopamine; Humans; In Vitro Techniques; Kinetics; Lobeline; Methamphetamine; Rats; Structure-Activity Relationship; Synaptic Vesicles; Tetrabenazine; Vesicular Monoamine Transport Proteins | 2015 |
Rapid Recovery of Vesicular Dopamine Levels in Methamphetamine Users in Early Abstinence.
Topics: Adult; Amphetamine-Related Disorders; Carbon Radioisotopes; Cocaine; Cognition Disorders; Corpus Striatum; Dopamine; Female; Humans; Male; Methamphetamine; Positron-Emission Tomography; Synaptic Vesicles; Tetrabenazine; Young Adult | 2016 |